Hepatology
Patient Information
Accelerated hepatitis A and B immunization program may help high-risk patients
News
Subclinical heart dysfunction, fatty liver linked
Patients from the CARDIA study who were determined to have NAFLD (10% of 2,713: 271) were found to have significant myocardial dysfunction and...
News
Ledipasvir-sofosbuvir plus ribavirin in advanced HCV does well
Key clinical point: Ledipasvir-sofosbuvir plus ribavirin for 12 weeks achieved high SVR rates among patients with hepatitis C virus infection and...
News
Less posttransplant primary biliary cirrhosis with preventive UDCA
Key clinical point: Treatment with prophylactic ursodeoxycholic acid might help prevent recurrent primary biliary cirrhosis after liver...
News
Cirrhosis in HCV often goes unreported
More than 28% of patients with chronic hepatitis C virus infection met at least one criterion for cirrhosis, while only 7% had biopsy confirmation...
Commentary
Cases of liver failure linked to “fat-burning” supplement
Applied Evidence
Hepatitis C: How to fine-tune your approach
Advances in drug therapy have made it possible to cure HCV infection. This article describes how best to screen, diagnose, and counsel these...